Latest filing published 02 Dec 2024 for Longboard Pharmaceuticals, Inc., €20.7M.
Filing timeline
BuySaleInsider track record
Kevin Robert Lind: trading record in brief
Filings by Kevin Robert Lind span 2 companies, the busiest being Arena Pharmaceuticals Inc and Longboard Pharmaceuticals, Inc. In total, 12 filings cover trades dated from 30 September 2016 to 2 December 2024.
On the market, this insider has only sold: 1 sale, €228k in total. Outside the open market, there are 1 share grant and 6 option exercises.
The record was last updated on 2 December 2024 with a transaction (€20.7M) in Longboard Pharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Robert Lind
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 363,740 shares@ US$60.0098.7% of flowCommon StockSEC:0001415889-24-028021:0
- 80,000 shares0Common StockSEC:0000950170-24-126650:1
- 12,808 shares@ US$3.12320.2% of flowCommon StockSEC:0000950170-24-126650:0
- 2,217 shares@ US$4.200.0% of flowCommon StockSEC:0000950170-24-096499:1
- 80,265 shares@ US$3.12321.1% of flowCommon StockSEC:0000950170-24-096499:0
- 2,500 shares@ US$19.409.5% of flowCommon StockSEC:0001209191-20-009834:0
- 2,000 shares@ US$35.6013.9% of flowCommon StockSEC:0001209191-20-009834:1
- 4,500 shares@ US$55.0048.4% of flowCommon StockSEC:0001209191-20-009834:2
- 6,300 shares0Common StockSEC:0001209191-19-053333:0
- 3,091 shares@ US$47.3228.2% of flowCommon StockSEC:0001209191-19-053333:1
- 625 shares@ US$1.410.2% of flowCommon StockSEC:0001209191-17-010903:0
- 625 shares@ US$1.210.2% of flowCommon StockSEC:0001209191-17-010903:1
12 of 12 declarations
